@misiu143 I'm not sure you read my posts. In

@misiu143

I'm not sure you read my posts.

In both of my posts I very clearly indicated that viral load was not worth measuring in the M/M trial:

Post 1 Link: https://investorshangout.com/post/view?id=5857914
Post 1 Excerpt:
"It's easy to understand why viral load was not included, not only is this a M/M cohort that might not show a dramatic increase or decrease in viral load ..."

Post 2 Link: https://investorshangout.com/post/view?id=5858032
Post 2 Excerpt:
"You are absolutely correct. The M/M cohort will probably not express meaningful viral load, or any associated delta."

We are not in disagreement.

Also, I very clearly stated that the FDA does not look at anything other than statistics:

Post 1 Link: https://investorshangout.com/post/view?id=5857914
Post 1 Excerpt:
"Dr.BP also described the FDA as being a statistical analysis-based organization and that they don't have the time or inclination to research papers on drugs they are reviewing. He was very clearly discounting the value of his peer reviewed paper in terms of influencing the FDA's approval process in our favor."

You also mention that I should let the company do their job:

Excerpt:
"IMO , lets the company do their job , look to me thy know what they doing...

Let me be clear when I say that I have NOT emailed the company -- a different member of this board emailed the company.

I try to chose my words very carefully. I hope this clears up any confusion you might have.

Lastly, I will say that it is nice to see you back and I hope you are able to post more frequently.